MUC1 and idiopathic pulmonary fibrosis: Nevertheless, unlike other studies that showed the role of KL-6 in predicting the prognosis of IPF regardless of antifibrotic treatment, we could infer that the role of KL-6 change is to predict treatment response by evaluating DP in patients with IPF who received antifibrotic agents.